RE:Revenue Generation They’ll do well, just not in the short term. Q3 financials are being released this month and it won’t be a good indicator of where they are at in terms of progress. It’ll report another big loss and won’t include the money from the recent bought deal as well.
1) They had very limited product available for rec. Their branding was on point but product availability really hurt them in the short term.
2) I read somewhere Germany its now up to 45,000 patients and I don’t see how they wouldn’t be selected as a cultivator in Germany.
3) They need to finish their facility without doing another raise before they can execute on this agreement. I’m worried with the volatility in the global markets, it may be difficult getting above $2+ for over 10 days.
4) The CBD capsules are only in Germany now and neither Ben nor Graham have spoke about the initial sales. I’m hoping this is their best kept secret.
5) In Switzerland they are currently wholesaling all their product according to Bens Interview so I don’t expect much revenues from there until 2019 Q2.
Lastly the AGM meeting is in December. For those constantly voicing their concerns, I do encourage you to participate. I see a lot of upcoming catalysts for Q4 2018 because I can’t imagine Wayland holding any typos of meeting with a ton of angry investors.
6 grow rooms are soon to be operational and waiting on health Canada approval. This stock will not run until investors see product on shelves and money being made. I really do see us being fine long term as their facility slowly comes online.
newsheriff95 wrote:
Rather than arguing with people that can't do their own research lets look at why the next FS could easily have 16 Million of revenue: 1) Rec sales to Canada, they had product ready to sell Oct 17th and are shipping more this week (per a recent interview) which will be sold out immediately 2) 16,000 medical patients in Germany - per the latest investor deck 3)-signs-minimum-9-000-kilograms-supply-agreement-with-cannamedical. Sales of CBD capsules in Europe 4) Sales of CBD cigarettes in Switzerland Get the picture? With tons of room to grow I could easily see 160 Million of revenue for 2019.